Back to Search Start Over

Antihypertensive Effects of a Soluble Guanylate Cyclase Stimulator.

Authors :
Bykov VV
Birulina YG
Nosarev AV
Vengerovskii AI
Udut VV
Source :
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2022 Nov; Vol. 174 (1), pp. 33-36. Date of Electronic Publication: 2022 Nov 28.
Publication Year :
2022

Abstract

We studied antihypertensive activity of an indolinone derivative (compound GRS), a soluble guanylate cyclase stimulator and a drug with previously proven antiaggregant effects. Contraction activity of isolated aorta segments of Wistar-Kyoto (WKY) rats was assessed in vitro using a mechanographic method. Addition of GRS (0.1-100 μМ) resulted in dose-dependent relaxation of endothelium-denuded aorta segments. Pretreatment of aorta smooth muscle segments with a specific inhibitor of soluble guanylate cyclase (ODQ, 1 μM) weakened the vasodilatory effect of GRS. Antihypertensive activity of the indolinone derivative GRS was studied in spontaneously hypertensive SHR rats. Single oral administration of 5 and 10 mg/kg GRS was followed by a significant dose-dependent reduction of systolic and diastolic BP in SHR rats. Antihypertensive effect of GRS in a dose of 5 mg/kg was more potent than that of the reference drug isosorbide dinitrate. GRS in a dose of 10 mg/kg did not affect systolic and diastolic BP in normotensive WKY rats.<br /> (© 2022. Springer Science+Business Media, LLC, part of Springer Nature.)

Details

Language :
English
ISSN :
1573-8221
Volume :
174
Issue :
1
Database :
MEDLINE
Journal :
Bulletin of experimental biology and medicine
Publication Type :
Academic Journal
Accession number :
36437315
Full Text :
https://doi.org/10.1007/s10517-022-05643-8